Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1995
08/16/1995EP0666919A1 Vaccine containing a thiol protease
08/16/1995EP0666917A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666911A1 Multidrug resistance gene
08/16/1995EP0666907A1 CULTURE CELLS OF $i(QUILLAJA SP.)
08/16/1995EP0666906A1 Cho cells expressing human endothelin receptors
08/16/1995EP0666904A1 Attenuated strains of aeromonas salmonicida useful as fish vaccines
08/16/1995EP0666870A1 PROTEIN FRAGMENTS OF THE $i(PECTINATUS) BACTERIUM
08/16/1995EP0666869A1 Peptides tolerizing t-cells and compositions thereof
08/16/1995EP0666868A1 Vascular endothelial cell growth factor antagonists
08/16/1995EP0666867A1 Reagents and methods for treating rheumatoid arthritis
08/16/1995EP0666866A1 Method of isolating biomolecules by ion exchange
08/16/1995EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
08/16/1995EP0666761A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies
08/16/1995EP0666760A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
08/16/1995EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
08/16/1995EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
08/16/1995EP0666751A1 Hepatitis a virus vaccines
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995EP0439462B1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
08/16/1995EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995CN1106980A Anti-aids immunomodulator complex
08/16/1995CN1106700A Triple oil emulsion inactivated vaccine for prevention and cure of chick disease and its preparation
08/15/1995US5442050 Isolated DNA sequences
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995US5441739 Reduced and controlled surface binding of biologically active molecules
08/15/1995US5441736 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
08/15/1995US5441703 Having conicoidal interior contour which homogeneously widens flow of reactant gases
08/15/1995CA1336739C Diphosphonate-derivatized macromolecules
08/15/1995CA1336692C Cloning and expression of the 47-kilodalton antigen of treponema pallidum
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336680C Method and compositions for the treatment and prevention of septic shock
08/10/1995WO1995021261A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
08/10/1995WO1995021258A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021255A1 Compositions useful in controlling marek's disease
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021192A1 Malaria merozoite antigen subunit vaccine
08/10/1995WO1995021189A1 Hepatitis b vaccine
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020978A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
08/10/1995WO1995020975A1 Tef-1 isoforms and uses thereof
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995WO1995001442A3 Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182723A1 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
08/10/1995CA2182708A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182498A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995CA2182375A1 Hepatitis b vaccine
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/09/1995EP0666271A1 Type 1 and type P fimbriae-adhesins isolated from novel E. coli strains, process for their preparation and uses thereof
08/09/1995EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens
08/09/1995EP0665955A1 Particles having gelatin-aminodextran coatings of and processes for making same
08/09/1995EP0665888A1 Ryegrass pollen allergen
08/09/1995EP0665887A1 Human 5-ht 2? receptor
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0490972B1 Recombinant negative strand rna virus expression systems and vaccines
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995CN1106299A Live in ovo vaccine
08/09/1995CN1106298A Anti-asthmatic and antitussive oral liquid
08/08/1995US5440021 A monoclonal antibody as antiinflammatory agent treating an inflammatory disorder
08/08/1995US5440017 T-cell lymphoma cDNA clones
08/08/1995US5440015 Selectin peptide medicaments for treating disease
08/08/1995US5439936 Administering an acylfulvene anticarcinogenic agents, adjuvants with surgical or radiation therapy; side effect reduction
08/08/1995US5439814 Inserting DNA into plasmid, genetic transcription of DNA into RNA, transfection of cells, recovering rubella for vaccines
08/08/1995US5439810 Manipulation of gene copy number in bordetella
08/08/1995US5439809 Non-infectious HIV particles lacking long terminal repeats
08/08/1995US5439808 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
08/08/1995US5439798 Maleimide adduct conjugates of procainamide and NAPA
08/08/1995US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator
08/08/1995US5439680 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
08/08/1995CA1336581C Aloe composition and uses thereof
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/03/1995WO1995020764A1 Specific binding substances for antibodies and their use for immunoassays or vaccines
08/03/1995WO1995020763A1 Piperidine analogs and conjugates of procainamide and napa
08/03/1995WO1995020673A1 Organo-phosphorus compounds as activators of gamma delta t cells
08/03/1995WO1995020665A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
08/03/1995WO1995020664A2 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
08/03/1995WO1995020658A2 Diagnosis and treatment of infections due to streptococci and enterococci
08/03/1995WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995WO1995020655A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/03/1995WO1995020605A1 Immuno-stimulatory monoclonal antibodies
08/03/1995WO1995020600A1 Immunogens against gonadotropin releasing hormone
08/03/1995WO1995020599A1 B cell epitope of mite allergen
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995DE4402756A1 Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine Specific binding substances for antibodies and their use for immunoassays or vaccine
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182170A1 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995CA2181898A1 Piperidine analogs and conjugates of procainamide and napa
08/03/1995CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/02/1995EP0665289A2 Peptides from GAD65, provoking autoimmune reactions
08/02/1995EP0665020A2 Method for preparing thioether conjugates
08/02/1995EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies
1 ... 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 ... 1823